OrbiMed’s Elevance Health ELV Stock Holding History

OrbiMed’s Portfolio ELV Stock Details ELV Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-106,200	Closed	-$55.2M	–	117
2024 Q3	$55.2M	Sell	106,200 -61,900	-37%	-$32.2M	1%	29
2024 Q2	$91.1M	Hold	168,100	–	–	1.8%	14
2024 Q1	$87.2M	Buy	168,100 +26,600	+19%	+$13.8M	1.6%	18
2023 Q4	$66.7M	Buy	+141,500	New	+$66.7M	1.33%	28
2021 Q4	–	Sell	-207,100	Closed	-$77.2M	–	161
2021 Q3	$77.2M	Sell	207,100 -128,600	-38%	-$47.9M	0.85%	36
2021 Q2	$128M	Buy	335,700 +49,100	+17%	+$18.7M	1.3%	23
2021 Q1	$103M	Sell	286,600 -23,900	-8%	-$8.58M	0.96%	32
2020 Q4	$99.7M	Buy	+310,500	New	+$99.7M	0.87%	32
2020 Q1	–	Sell	-106,600	Closed	-$32.2M	–	145
2019 Q4	$32.2M	Sell	106,600 -148,000	-58%	-$44.7M	0.46%	55
2019 Q3	$61.1M	Sell	254,600 -107,000	-30%	-$25.7M	1.16%	31
2019 Q2	$102M	Buy	361,600 +36,400	+11%	+$10.3M	1.58%	17
2019 Q1	$93.3M	Buy	325,200 +19,800	+6%	+$5.68M	1.44%	18
2018 Q4	$80.2M	Sell	305,400 -168,600	-36%	-$44.3M	1.48%	19
2018 Q3	$130M	Sell	474,000 -57,800	-11%	-$15.8M	1.56%	19
2018 Q2	$127M	Buy	+531,800	New	+$127M	1.51%	19
2018 Q1	–	Sell	-658,718	Closed	-$148M	–	132
2017 Q4	$148M	Sell	658,718 -268,900	-29%	-$60.5M	1.87%	15
2017 Q3	$176M	Buy	927,618 +7,000	+0.8%	+$1.33M	1.68%	16
2017 Q2	$173M	Buy	920,618 +58,018	+7%	+$10.9M	1.82%	18
2017 Q1	$143M	Sell	862,600 -159,000	-16%	-$26.3M	1.62%	19
2016 Q4	$147M	Buy	+1,021,600	New	+$147M	1.87%	18
2015 Q1	–	Sell	-138,800	Closed	-$17.4M	–	126
2014 Q4	$17.4M	Buy	138,800 +20,300	+17%	+$2.55M	0.17%	77
2014 Q3	$14.2M	Buy	118,500 +58,500	+98%	+$7M	0.15%	79
2014 Q2	$6.46M	Buy	+60,000	New	+$6.46M	0.08%	93
2014 Q1	–	Sell	-429,000	Closed	-$39.6M	–	124
2013 Q4	$39.6M	Sell	429,000 -777,000	-64%	-$71.8M	0.58%	45
2013 Q3	$101M	Buy	1,206,000 +19,000	+2%	+$1.59M	1.8%	20
2013 Q2	$97.1M	Buy	+1,187,000	New	+$97.1M	2.06%	15